325 related articles for article (PubMed ID: 22049245)
1. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma.
Rossing M; Borup R; Henao R; Winther O; Vikesaa J; Niazi O; Godballe C; Krogdahl A; Glud M; Hjort-Sørensen C; Kiss K; Bennedbæk FN; Nielsen FC
J Mol Endocrinol; 2012 Feb; 48(1):11-23. PubMed ID: 22049245
[TBL] [Abstract][Full Text] [Related]
2. Molecular signatures of thyroid follicular neoplasia.
Borup R; Rossing M; Henao R; Yamamoto Y; Krogdahl A; Godballe C; Winther O; Kiss K; Christensen L; Høgdall E; Bennedbaek F; Nielsen FC
Endocr Relat Cancer; 2010 Sep; 17(3):691-708. PubMed ID: 20668010
[TBL] [Abstract][Full Text] [Related]
3. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer.
Akaishi J; Onda M; Okamoto J; Miyamoto S; Nagahama M; Ito K; Yoshida A; Shimizu K
BMC Cancer; 2006 Nov; 6():260. PubMed ID: 17076909
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
7. Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.
Pallante P; Visone R; Croce CM; Fusco A
Endocr Relat Cancer; 2010 Mar; 17(1):F91-104. PubMed ID: 19942715
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation of miRNA and cell cycle-associated genes suggests influence of miRNA on benign thyroid nodule tumorigenesis.
Ferraz C; Lorenz S; Wojtas B; Bornstein SR; Paschke R; Eszlinger M
J Clin Endocrinol Metab; 2013 Jan; 98(1):E8-16. PubMed ID: 23144465
[TBL] [Abstract][Full Text] [Related]
9. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma.
Weber F; Teresi RE; Broelsch CE; Frilling A; Eng C
J Clin Endocrinol Metab; 2006 Sep; 91(9):3584-91. PubMed ID: 16822819
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications.
Chevillard S; Ugolin N; Vielh P; Ory K; Levalois C; Elliott D; Clayman GL; El-Naggar AK
Clin Cancer Res; 2004 Oct; 10(19):6586-97. PubMed ID: 15475448
[TBL] [Abstract][Full Text] [Related]
11. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
Wojtas B; Ferraz C; Stokowy T; Hauptmann S; Lange D; Dralle H; Musholt T; Jarzab B; Paschke R; Eszlinger M
Mol Cell Endocrinol; 2014 May; 388(1-2):1-9. PubMed ID: 24631480
[TBL] [Abstract][Full Text] [Related]
12. A two miRNA classifier differentiates follicular thyroid carcinomas from follicular thyroid adenomas.
Stokowy T; Wojtaś B; Krajewska J; Stobiecka E; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Jarząb B; Krohn K; Paschke R; Eszlinger M
Mol Cell Endocrinol; 2015 Jan; 399():43-9. PubMed ID: 25258301
[TBL] [Abstract][Full Text] [Related]
13. miRNAs with the potential to distinguish follicular thyroid carcinomas from benign follicular thyroid tumors: results of a meta-analysis.
Stokowy T; Wojtaś B; Fujarewicz K; Jarząb B; Eszlinger M; Paschke R
Horm Metab Res; 2014 Mar; 46(3):171-80. PubMed ID: 24446156
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
[TBL] [Abstract][Full Text] [Related]
15. miR-191 down-regulation plays a role in thyroid follicular tumors through CDK6 targeting.
Colamaio M; Borbone E; Russo L; Bianco M; Federico A; Califano D; Chiappetta G; Pallante P; Troncone G; Battista S; Fusco A
J Clin Endocrinol Metab; 2011 Dec; 96(12):E1915-24. PubMed ID: 21956418
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
[TBL] [Abstract][Full Text] [Related]
17. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
18. Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) gene.
Colamaio M; Calì G; Sarnataro D; Borbone E; Pallante P; Decaussin-Petrucci M; Nitsch L; Croce CM; Battista S; Fusco A
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2168-78. PubMed ID: 22965940
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer.
Geraldo MV; Yamashita AS; Kimura ET
Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
